îæ€çŽ¢
îæ€çŽ¢
î
Spyre Therapeutics Inc
SYREîãŠã©ãããªã¹ãã«è¿œå
98.330USD
-3.170-3.12%
çµå€Â 07-31 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
8.54Bæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-07-31Spyre Therapeutics Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯9.18ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯385瀟äž10äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯49.00ã§ãæé«ã¯70.00ãæäœã¯21.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
17
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
105.786
ç®æšæ ªäŸ¡
+8.09%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
496
åèš
6
äžå€®å€
7
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Spyre Therapeutics Inc
SYRE
17
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
Spyre Therapeutics Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãSpyre Therapeutics Inc ã®ç®æšæ ªäŸ¡ã USD 49.00 ãšäºæ³ããæé«äºæ³ã¯ USD 70.00ãæäœäºæ³ã¯ USD 21.00 ãšäºæ³ããŠããŸãã
Spyre Therapeutics IncSYRE ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.88 ã§ããããSpyre Therapeutics IncSYRE ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.83 ã§ããã次ã®ååæã® EPS 㯠USD -0.76 ãšäºæ³ãããŸãã
Spyre Therapeutics Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î17 ã¢ããªã¹ãã«ãã Spyre Therapeutics Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Spyre Therapeutics Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã